P

General Information


DRACP ID  DRACP00252

Peptide Name   P

Sequence  KWKSFLKTFKSAKKTVLHTALKAISS

Sequence Length  26

UniProt ID  Not available

PubChem CID  Not available

Origin  PeptideV13K

Type  Synthetic peptide

Classification

  

Active ACP Membrane-targeted



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
A549 Lung adenocarcinoma Carcinoma IC50=33 μmol/L MTT assay 36 h 1
A-375 Amelanotic melanoma Carcinoma IC50=17.8 μmol/L MTT assay 36 h 1
MCF-7 Invasive breast carcinoma of no special type Carcinoma IC50=15.8 μmol/L MTT assay 36 h 1
SW1116 Colon adenocarcinoma Carcinoma IC50=11.1 μmol/L MTT assay 36 h 1
RD Embryonal rhabdomyosarcoma Sarcoma IC50=25.2 μmol/L MTT assay 36 h 1
NCI-H1299 Lung large cell carcinoma Carcinoma IC50=4.7 μmol/L MTT assay 36 h 1
B16 Mouse melanoma Carcinoma IC50=11.5 μmol/L MTT assay 36 h 1
HeLa Human papillomavirus-related endocervical adenocarcinoma Carcinoma IC50=10.4 μmol/L MTT assay 36 h 1

Hemolytic Activity  Human red blood cells: MHC=167.2 ± 5.91 μmol/L

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Peptides killed cancer cells with a fast necrotic mechanism causing cell membrane lysis

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP00252

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C139H230N36O34

Absent amino acids  CDEGMNPQRY

Common amino acids  K

Mass  339567

Pl  11.58

Basic residues  8

Acidic residues  0

Hydrophobic residues  11

Net charge  8

Boman Index  -2738

Hydrophobicity  -21.54

Aliphatic Index  82.69

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  5500

Absorbance 280nm  220

Polar residues  7

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 21252288

Title  Studies on mechanism of action of anticancer peptides by modulation of hydrophobicity within a defined structural framework

Doi 10.1158/1535-7163.MCT-10-0811

Year  2011

Literature 2

Pubmed ID 15677462

Title  Rational design of alpha-helical antimicrobial peptides with enhanced activities and specificity/therapeutic index

Doi 10.1074/jbc.M413406200

Year  2005

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.